HealthQuill GLP-1 drugs
Eli Lilly will invest an additional $450 million to expand its manufacturing capacity at Research Triangle Park facility in North Carolina.
Pharma

The weight-loss drug race just got crowded

Jay Shankar July 21, 2026: Global obesity medicine sales hit $66 billion in 2025 and are on track to reach $92 billion this.

Read More
Six small ribonucleic acid (RNA) molecules in the blood may be able to predict short-term survival with an 86% accuracy, a study finds.
Health Medical Research

A blood test can reveal your short-term survival period: Study

Six small ribonucleic acid (RNA) molecules in the blood may be able to predict short-term survival with an 86% accuracy, a study finds.

Read More
Novo Nordisk’s medicine Wegovy, at a higher dose, resulted in an average weight loss of 21% during trials in people with obesity compared to a dummy drug, the company stated.
Drugs Health Pharma

Wegovy’s weight-loss efficacy improves with higher dosage

HQ Team June 21, 2025: Novo Nordisk’s medicine Wegovy, at a higher dose, resulted in an average weight loss of 21% during trials.

Read More
Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in lowering blood sugar levels.
Drugs Medical Pharma

‘Pharma firms manipulate patents to curb competition and drive prices’

A study conducted by researchers from Harvard University has revealed a concerning trend within the pharmaceutical industry— the widespread adoption of intricate patent.

Read More